Our most advanced candidate, danuglipron, has shown good efficacy in a twice-daily formulation, and we believe a once-daily formulation could be highly competitive in the oral GLP-1 space, said Mikael Dolsten, MD., PhD., Chief Scientific Officer & President, Pfizer Research and Development
This 150+ genetic insight analysis explains whether you're likely to see faster or slower initial appetite suppression and helps your provider optimize your dose timing
You can pick a range of supplements from most shelves in most supermarkets and chemists, a range of strengths, prices and brands
The pricing page lists every option across every pharmacy in advance
it's about fighting a food environment engineered for dopamine hits and overconsumption, while building the kind of metabolic resilience that pays dividends for decades